These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9673406)

  • 1. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
    Kavallaris M; Gardaneh M; Cheung B; Camacho ML; Hocker JE; Norris MD; Haber M; Marshall GM
    Anticancer Res; 1998; 18(3A):1793-7. PubMed ID: 9673406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
    Sarkar AK; Nuchtern JG
    Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MycN sensitizes neuroblastoma cells for drug-induced apoptosis.
    Fulda S; Lutz W; Schwab M; Debatin KM
    Oncogene; 1999 Feb; 18(7):1479-86. PubMed ID: 10050884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
    Lutz W; Fulda S; Jeremias I; Debatin KM; Schwab M
    Oncogene; 1998 Jul; 17(3):339-46. PubMed ID: 9690515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
    Shohet JM; Hicks MJ; Plon SE; Burlingame SM; Stuart S; Chen SY; Brenner MK; Nuchtern JG
    Cancer Res; 2002 Feb; 62(4):1123-8. PubMed ID: 11861392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
    Prochazka P; Hrabeta J; Vícha A; Eckschlager T
    Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.
    Teitz T; Wei T; Valentine MB; Vanin EF; Grenet J; Valentine VA; Behm FG; Look AT; Lahti JM; Kidd VJ
    Nat Med; 2000 May; 6(5):529-35. PubMed ID: 10802708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
    Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM
    Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC; Schürmann J; Schwab M
    Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N; Seeger RC; Groshen S; Reynolds CP
    Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
    Chen J; Liu T; Zhe X; Jiang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased expression of the MYCN oncogene in human neuroblastoma cells and possible, new therapeutic approaches].
    Schweigerer L; Fotsis T
    Klin Padiatr; 1991; 203(4):319-22. PubMed ID: 1942938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N; Balmas Bourloud K; Brognara CB
    Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line.
    Negroni A; Scarpa S; Romeo A; Ferrari S; Modesti A; Raschellà G
    Cell Growth Differ; 1991 Oct; 2(10):511-8. PubMed ID: 1751406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
    Schneider SS; Zehnbauer BA; Vogelstein B; Brodeur GM
    Prog Clin Biol Res; 1991; 366():71-6. PubMed ID: 2068181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.